> >>Epstein Barr Virus Early Antigen (EA) IgG ELISA kit
View larger

Epstein Barr Virus Early Antigen (EA) IgG ELISA kit

NR-R10043

$672.00

More info

Principle
Indirect ELSIA, Antigen coated plate
 
Detection Range
Qualitative Positive; Negative and Cut off
 
Size
96T
 
Specificity                      99%

Sensitivity                      99%
 
Assay time
~ 100 min
 
Shelf Life
12~18 Months from the Manufacturing Date
 
Storage
Store at 2 - 8ºC. 
 
Sample volume
10 µL Serum or Plasma
 
Detection Method
Chromogenic
  
Kit Components
 
 
 
1. 20 x Wash Buffer: 1vial 
 
 
2. One 96-well plate precoated with recombinant antigen
 
 
3. Assa diluent buffer: 1 vial
 
 
4. HRP conjugated: 1 vial
 
 
5. Positive Control: 1 vial
 
 
6. Negative Control:1vial
 
 
7. Calibrator: 1 vial
 
 
8. TMB substrate: 1 vial
 
 
9. TMB stop solution: 12 ml.

 

Background

 

Epstein-Barr virus (EBV), a member of the herpesvirus group, is the etiologic agent of infectious mononucleosis. The Epstein-Barr virus (EBV) early antigen (EA) complex consists of multiple proteins with relevance for diagnosis of acute, chronic and malignant EBV related diseases, including nasopharyngeal carcinoma (NPC). The presence of antibody to the early antigen (EA) of Epstein-Barr virus (EBV) indicates that EBV is actively replicating. Generally, this antibody can only be detected during active EBV infection, such as in patients with infectious mononucleosis. Clinical studies have indicated that patients who have chronic active or reactivated EBV infection commonly have elevated levels of IgG-class antibodies to the EA of EBV. 

Download

protocol

Download (0)

© 2024 Novateinbio.com